trending Market Intelligence /marketintelligence/en/news-insights/trending/IoG9g4BoVUs52V0PfvceBg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Assembly Biosciences chief scientific officer to step down

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Assembly Biosciences chief scientific officer to step down

Assembly Biosciences, Inc. said Miguel Barbosa will step down as chief scientific officer and head of the microbiome program, effective Oct. 31.

The company said Barbosa's resignation is due to family medical reasons, and is unrelated to the company or his performance.

Barbosa will remain with the company as a consultant in a strategic advisory role and to assist with the leadership transition.

While the company searches for a replacement, Wayne Herber, senior vice president for biological manufacturing, and Thomas Rollins, chief development officer, will jointly lead the microbiome program.